We are live on ! Find out more
IFRX icon

InflaRx
IFRX

46 hedge funds and large institutions have $548M invested in InflaRx in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 5

143% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 7

35% more funds holding

Funds holding: 34 → 46 (+12)

14% more capital invested

Capital invested by funds: $482M → $548M (+$66.7M)

4.84% more ownership

Funds ownership: 51.05% → 55.89% (+4.8%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
46
Holders Change
+12
Holders Change %
+35.29%
% of All Funds
1%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
17
Increased
17
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$41.5M
2
RCM
RA Capital Management
Massachusetts
+$27M
3
AG
Artal Group
Luxembourg
+$12.1M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.47M
5
KCM
Kingdon Capital Management
New York
+$6.53M

Top Sellers

Rank Fund Capital Flow
1
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$38.5M
2
BlackRock
BlackRock
New York
-$30.9M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$15.2M
4
PC
Polar Capital
United Kingdom
-$5.16M
5
Millennium Management
Millennium Management
New York
-$1.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$2.3M +$1.15M +30,961 +104%
Renaissance Technologies
27
Renaissance Technologies
New York
$2.2M +$2.17M +58,300 New
Artisan Partners
28
Artisan Partners
Wisconsin
$1.97M +$515K +13,834 +36%
Millennium Management
29
Millennium Management
New York
$1.41M -$1.3M -34,785 -48%
IBT
30
International Biotechnology Trust
United Kingdom
$1.22M +$1.21M +32,500 New
BC
31
Birchview Capital
Vermont
$605K – – –
BCM
32
BlueCrest Capital Management
Jersey
$567K +$559K +15,000 New
Geode Capital Management
33
Geode Capital Management
Massachusetts
$504K +$247K +6,630 +99%
ARTA
34
A.R.T. Advisors
New York
$448K +$442K +11,862 New
CG
35
Carmignac Gestion
France
$404K +$398K +10,688 New
WMSA
36
Weiss Multi-Strategy Advisers
New York
$378K – – –
SIM
37
Spark Investment Management
New York
$359K +$354K +9,500 New
CSS
38
Cubist Systematic Strategies
Connecticut
$344K +$340K +9,114 New
Northern Trust
39
Northern Trust
Illinois
$280K +$6.56K +176 +2%
TRCT
40
Tower Research Capital (TRC)
New York
$32K +$9.57K +257 +43%
PRC
41
Pearl River Capital
Michigan
$24K +$24.6K +660 New
Citigroup
42
Citigroup
New York
$19K +$1.68K +45 +10%
UBS Group
43
UBS Group
Switzerland
$17K +$16.7K +449 New
PCM
44
Prelude Capital Management
New York
$5K -$559 -15 -11%
Wells Fargo
45
Wells Fargo
California
$4K +$3.91K +105 New
PHK
46
Point72 Hong Kong
Hong Kong
$1K – – –
PC
47
Polar Capital
United Kingdom
– -$5.16M -141,887 Closed
EIM
48
Essex Investment Management
Massachusetts
– -$798K -21,937 Closed
Bank of America
49
Bank of America
North Carolina
– -$657K -18,070 Closed
PP
50
Paloma Partners
Connecticut
– -$526K -14,453 Closed
1
2
3

IFRX Hedge Fund Activity: Q1 2019 in Review

46 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q1 2019, worth a combined $548M — up 14% from $482M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IFRX positions and 5 closed out — a net gain of 12 holders — while 17 added to existing stakes and 7 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $41.5M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $38.5M.

  • 46 institutional investors held InflaRx (IFRX) as of Q1 2019, up from 34 in Q4 2018.
  • Funds reported $548M of InflaRx stock for Q1 2019, up 14% quarter-over-quarter.
  • 17 funds opened new InflaRx positions in Q1 2019 and 5 closed out, a net change of +12 holders.
  • The largest InflaRx buyer in Q1 2019 was Cormorant Asset Management, an estimated $41.5M added.
  • The largest InflaRx seller in Q1 2019 was Bain Capital Life Sciences Investors, an estimated $38.5M sold.

Based on aggregated 13F filings for Q1 2019.